Clinical and Experimental Ophthalmology

Papers
(The H4-Index of Clinical and Experimental Ophthalmology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Continuing Professional Development232
Issue Information109
Issue Information93
Mimickers of hydroxychloroquine retinal toxicity77
Stromal Curvature, Power and Corneal‐Stromal Curvature Ratios From a Hybrid ASOCT in Eyes With Keratoconus68
The Long Journey of Treatment for Wet Macular Degeneration, Is It Worth It?66
Fluid misdirection syndrome associated with endothelial keratoplasty: A multicenter case series62
Recent advances in the use of optical coherence tomography in neuro‐ophthalmology: A review57
Circular RNA expression profile and functional analysis of circUvrag in light‐induced photoreceptor degeneration49
Improved methods for isolating the mouse retinal vasculature43
Telemedicine and delivery of ophthalmic care in rural and remote communities: Drawing from Australian experience42
Proposal of a Simpler Eye‐Level Risk Model Incorporating Reticular Pseudodrusen for the Clinical Prediction of Late Age‐Related Macular Degeneration41
Genetics in neovascular age‐related macular degeneration susceptibility and treatment response to anti‐VEGF intravitreal injection: A case series study39
The association between keratoconus and allergic eye diseases: A systematic review and meta‐analysis38
Bevacizumab biosimilar (bevacizumab‐awwb) is safe in the treatment of retinopathy of prematurity37
Issue Information37
Continuing Professional Development33
Continuing Professional Development26
26
Issue Information26
Optimised minus lens overcorrection for paediatric intermittent exotropia: A randomised clinical trial24
Publishing opportunities and gender equity: Embedding monitoring in eye health education24
Continuing Professional Development24
‘Closing the gap’ on visual acuity outcomes of Indigenous and remote patients receiving intravitreal injections in Northern Australia23
0.68145108222961